You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KIF18A Inhibitor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (JTX-4014, Vopratelimab)

Active, not recruiting
  • NSCLC
  • Minsk, Belarus
  • +70 more
Jan 18, 2023

Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

Not yet recruiting
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Paris, France
    Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022

Pneumonitis Trial in Chongqing (single-cell sequencing)

Not yet recruiting
  • Pneumonitis
  • single-cell sequencing
  • Chongqing, Chongqing, China
    Xinqiao Hospital
Jul 12, 2022

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed
  • Solid Tumors
  • +3 more
  • Telaglenestat (CB-839)
  • Palbociclib Oral Capsule or Tablet [Ibrance]
  • Santa Monica, California
  • +9 more
Sep 14, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Dysbiosis Trial in Graz (Intervention)

Not yet recruiting
  • Dysbiosis
  • Intervention
  • Graz, Austria
    Medical University Graz
Apr 18, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Immune Checkpoint Inhibitor-related Cardiotoxicity

Not yet recruiting
  • Immune Checkpoint Inhibitors, Cardiotoxicity
  • Cardiac magnetic resonance
  • (no location specified)
Nov 10, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jul 28, 2023

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Beijing, China
  • +1 more
Sep 21, 2023

NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • L-TIL, Tislelizumab, Docetaxel
  • Zhengzhou, Henan, China
    No.127 Dongming Road
May 17, 2023

NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Davis, California
  • +1 more
Dec 22, 2022

NSCLC Trial in United States (VIC-1911, sotorasib)

Recruiting
  • Non-small Cell Lung Cancer
  • Sacramento, California
  • +4 more
Jan 5, 2023

Type 2 Diabetes Trial in Canada, United States (BMF-219)

Recruiting
  • Type 2 Diabetes Mellitus
  • Montclair, California
  • +5 more
Feb 22, 2023

Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

Not yet recruiting
  • Diabetic Nephropathy Type 2
  • Tadalafil 20Mg Oral Tablet
  • Pentoxifylline 400 MG Oral Tablet
  • (no location specified)
Aug 2, 2022

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Solid Tumor Trial in Madison (drug, other, procedure)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • VEGFR/PDGFR dual kinase inhibitor X-82
  • +5 more
  • Madison, Wisconsin
    University of Wisconsin-Carbone Cancer Center
Nov 14, 2019

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligometastatic Disease
  • (no location specified)
May 5, 2023